JANEL CORP 10-Q

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS There were no unregistered sales of equity securities during the six months ended March 31, 2024. In addition, there were no shares of Common Stock purchased by us during the six months ended March 31, 2024. ITEM 6. EXHIBIT INDEX 10.1 First Amendment to Amended and Restated Credit Agreement, by and among Indco, Inc. a Tennessee corporation, Antibodies Incorporated, a California corporation, Aves Labs, Inc., an Oregon corporation, PhosphoSolutions LLC, a Nevada limited liability company, ImmunoChemistry Technologies LLC, a Minnesota limited liability company, ECM BioSciences, LLC, a Kentucky limited liability company, Stephen Hall, PHD LTD, an Indiana corporation, ImmunoBioScience Corp., a Washington corporation (collectively as borrowers) and Janel Corporation, a Nevada corporation, as guarantor, and First Merchants Bank, as bank. dated January 10, 2024 31.1 Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer (filed herewith) 31.2 Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer (filed herewith) 32.1 Section 1350 Certification of Principal Executive Officer (filed herewith) 32.2 Section 1350 Certification of Chief Financial Officer (filed herewith) 101 Interactive data files providing financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 for the three and six months ended March 31, 2024 and 2023 in Inline XBRL (eXtensible Business Reporting Language) pursuant to Rule 405 of Regulation S-T: (i) Condensed Consolidated Balance Sheets as of March 31, 2024 and September 30, 2023, (ii) Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2024 and 2023, (iii) Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and six months March 31, 2024 and 2023, (iv) Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2024 and 2023, and (v) Notes to Condensed Consolidated Financial Statements. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Interactive Data Files submitted as Exhibit 101) (filed herewith) 26 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: May 3, 2024 JANEL CORPORATION Registrant /s/ Darren C. Seirer Darren C. Seirer Chairman, President and Chief Executive Officer ( Principal Executive Officer) Dated: May 3, 2024 JANEL CORPORATION Registrant /s/ Joseph R. Ferrara Joseph R. Ferrara Chief Financial Officer, Treasurer and Secretary 27